| Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11 X Wang, Y Chen, X Wang, H Tian, Y Wang, J Jin, Z Shan, Y Liu, Z Cai, ... Cancer research 81 (20), 5217-5229, 2021 | 174 | 2021 |
| Emerging phagocytosis checkpoints in cancer immunotherapy Y Liu, Y Wang, Y Yang, L Weng, Q Wu, J Zhang, P Zhao, L Fang, Y Shi, ... Signal transduction and targeted therapy 8 (1), 104, 2023 | 139 | 2023 |
| The diversified role of mitochondria in ferroptosis in cancer Y Liu, S Lu, L Wu, L Yang, L Yang, J Wang Cell death & disease 14 (8), 519, 2023 | 124 | 2023 |
| An Overview: The Diversified Role of Mitochondria in Cancer Metabolism Y Liu, Y Sun, Y Guo, X Shi, X Chen, W Feng, LL Wu, J Zhang, S Yu, ... International Journal of Biological Sciences 19 (3), 897, 2023 | 107 | 2023 |
| Mitochondria as a target in cancer treatment Y Liu, Y Shi MedComm 1 (2), 129-139, 2020 | 97 | 2020 |
| An epigenetic role of mitochondria in cancer Y Liu, C Chen, X Wang, Y Sun, J Zhang, J Chen, Y Shi Cells 11 (16), 2518, 2022 | 93 | 2022 |
| Ferroptosis in life: To be or not to be L Xu, Y Liu, X Chen, H Zhong, Y Wang Biomedicine & Pharmacotherapy 159, 114241, 2023 | 64 | 2023 |
| Baicalein inhibits SARS-CoV-2/VSV replication with interfering mitochondrial oxidative phosphorylation in a mPTP dependent manner S Huang, Y Liu, Y Zhang, R Zhang, CJ Zhu, L Fan, G Pei, B Zhang, Y Shi Signal transduction and targeted therapy 5 (1), 266, 2020 | 64 | 2020 |
| Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity L Fang, Y Hao, H Yu, X Gu, Q Peng, H Zhuo, Y Li, Z Liu, J Wang, Y Chen, ... Cancer Cell 41 (6), 1118-1133. e12, 2023 | 54 | 2023 |
| NNMT‐DNMT1 axis is essential for maintaining cancer cell sensitivity to oxidative phosphorylation inhibition C Wu, Y Liu, W Liu, T Zou, S Lu, C Zhu, L He, J Chen, L Fang, L Zou, ... Advanced Science 10 (1), 2202642, 2023 | 25 | 2023 |
| Immunoregulation in cancer-associated cachexia Q Wu, Z Liu, B Li, Y Liu, P Wang Journal of Advanced Research 58, 45-62, 2024 | 21 | 2024 |
| Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition Y Liu, S Zhao, Y Chen, W Ma, S Lu, L He, J Chen, X Chen, X Zhang, Y Shi, ... Cellular Oncology 46 (6), 1791-1806, 2023 | 21 | 2023 |
| Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy X Gu, Y Liu, X Dai, YG Yang, X Zhang Frontiers in Immunology 14, 1137107, 2023 | 21 | 2023 |
| Deciphering the role of QPCTL in glioma progression and cancer immunotherapy Y Liu, S Lu, Y Sun, F Wang, S Yu, X Chen, L Wu, H Yang, Y Shi, K Zhao Frontiers in immunology 14, 1166377, 2023 | 19 | 2023 |
| Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance Y Liu, Y Chen, F Wang, J Lin, X Tan, C Chen, L Wu, X Zhang, Y Wang, ... Discover Oncology 14 (1), 161, 2023 | 16 | 2023 |
| Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer X Zhang, X Wang, L Hou, Z Xu, Y Liu, X Wang Frontiers in Pharmacology 14, 1130937, 2023 | 16 | 2023 |
| Deciphering the role of CD47 in cancer immunotherapy Y Liu, L Weng, Y Wang, J Zhang, Q Wu, P Zhao, Y Shi, P Wang, L Fang Journal of Advanced Research 63 (63:129-158), https://www.sciencedirect.com …, 2024 | 15 | 2024 |
| Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy JF Shi, Y Liu, Y Wang, R Gao, Y Wang, J Liu Frontiers in Pharmacology 14, 1194343, 2023 | 15 | 2023 |
| Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer M Wang, L Zhu, X Yang, J Li, Y Liu, Y Tang Frontiers in Pharmacology 14, 1132158, 2023 | 13 | 2023 |
| Functions of glutaminyl cyclase and its isoform in diseases Y Liu, Y Shi, P Wang Visualized Cancer Medicine 4, 1, 2023 | 13 | 2023 |
Ping WangEast China Normal UniversityVerifierad e-postadress på bio.ecnu.edu.cn